Hepatocellular carcinoma with portal vein tumor thrombosis: Improved treatment outcomes with external beam radiation therapy

Hepatology Research

Volumn 41, Issue 9, 2011, Pages 813-824

  Kim, Ji Yoon ^a   Chung, Su Mi ^a   Choi, Byung Ock ^a   Kay, Chul Seung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Hepatocellular carcinoma; Portal vein tumor thrombosis; Radiotherapy

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; AMINOTRANSFERASE; ANTIVIRUS AGENT; CAPECITABINE; GAMMA GLUTAMYLTRANSFERASE;

ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASCITES; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED RADIOTHERAPY; CYBERKNIFE; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; MULTIMODALITY CANCER THERAPY; PORTAL VEIN THROMBOSIS; PORTAL VEIN TUMOR THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTON THERAPY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEREOTACTIC BODY RADIATION THERAPY; THREE DIMENSIONAL IMAGING; TOMOTHERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS HEPATITIS;

EID: 80052230611     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00826.x     Document Type: Review

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Bosch FX, Ribes J, Borrs J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19: 271-85.
3. Ministry of Health and Welfare. 2007 Annual Report of the Korea Central Cancer Registry. Gyeonggi-do: Ministry of Health and Welfare, 2010.
4. Pirisi M, Avellini C, Fabris C etal. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin 1998; 124: 397-400.
5. Park KW, Park J, Choi JI etal. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 2008; 23: 467-73.
6. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996; 77: 2217-22.
7. Ikai I, Hatano E, Hasegawa S etal. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 2006; 202: 431-8.
8. Ando E, Tanaka M, Yamashita F etal. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 2002; 95: 588-95.
9. Hawkins MA, Dawson LA. Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 2006; 106: 1653-63.
10. Cheng JC, Wu J, Huang C etal. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys 2002; 54: 156-62.
11. Kim DY, Park W, Lim DH etal. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 2005; 103: 2419-26.
12. Kim TH, Kim DY, Park J etal. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol 2006; 29: 568-75.
13. Toya R, Murakami R, Baba Y etal. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol 2007; 84: 266-71.
14. Zeng Z, Fan J, Tang Z etal. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy. Cancer Sci 2008; 99: 2510-17.
15. Huang Y, Hsu H, Wang C etal. The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009; 73: 1155-63.
16. Kim JH, Yoon HK, Kim SY etal. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis. Aliment Pharmacol Ther 2009; 29: 1291-8.
17. Tazawa J, Maeda M, Sakai Y etal. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 2001; 16: 660-5.
18. Yamada K, Izaki K, Sugimoto K etal. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2003; 57: 113-19.
19. You CR, Jang JW, Kang SH etal. Efficacy of transarterial chemolipiodolization with or without 3-dimensional conformal radiotherapy for huge HCC with portal vein tumor thrombosis. Korean J Hepatol 2007; 13: 378-86.
20. Han K, Seong J, Kim JK, Ahn SH, Lee DY, Chon CY. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. Cancer 2008; 113: 995-1003.
21. Katamura Y, Aikata H, Takaki S etal. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis. J Gastroenterol 2009; 44: 492-502.
22. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007; 25: 947-52.
23. Choi BO, Choi IB, Jang HS etal. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer 2008; 8: 351-8.
24. Kay CS, Jang JW, Bae CS, Choi JY, Yoon SK, Choi IB. Clinical experience of helical tomotherapy for unresectable hepatocellular carcinoma. 93rd Scientific Assembly and Annual Meeting in Radiological Society of North America 2007; 155.
25. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 2006; 16: 77-84.
26. Jang JW, Kay CS, You CR etal. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys 2009; 74: 412-18.
27. Kim JY, Kay CS, Kim YS etal. Helical tomotherapy for simultaneous multitarget radiotherapy for pulmonary metastasis. Int J Radiat Oncol Biol Phys 2009; 75: 703-10.
28. Sugahara S, Nakayama H, Fukuda K etal. Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol 2009; 185: 782-8.
29. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995; 31: 1237-48.
30. Kim TH, Kim DY, Park J etal. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2007; 67: 225-31.
31. Cheng JC, Wu J, Lee PC etal. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2004; 60: 1502-9.
32. Mornex F, Girard N, Beziat C etal. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies - mature results of the French Phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006; 66: 1152-8.
33. Shim SJ, Seong J, Lee IJ, Han KH, Chon CY, Ahn SH. Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma. Hepatol Res 2007; 37: 906-13.